Two clinicians—a psychiatric prescriber and a hospital clinical pharmacist—weigh in on when to add a glucagon-like peptide-1 (GLP-1) receptor agonist for patients with serious mental illness (SMI), how to monitor for trouble, and how to set expectations at the counter.